Grey Matters Health Inc. (CSE: GREY) has announced an increase to its non-brokered private placement offering, lifting the total aggregate gross proceeds target to CAD $1.1 million. The Canadian healthcare company, focused on brain-dedicated PET scanning services for Alzheimer's and other neurodegenerative diseases, previously closed a first tranche on September 10, 2026, raising CAD $600,000. The expanded offering adds a second tranche of CAD $500,000 split equally between equity and convertible debenture units, with closing expected on or before September 21, 2026.
Key Points
- Grey Matters Health Inc. (CSE: GREY, Frankfurt: AGW0, OTC: AGNPF) is a Canadian neuroimaging-focused healthcare company
- Total gross proceeds target increased to CAD $1.1 million via a second tranche of equity and convertible debenture units
- First tranche closed September 10, 2026, raising CAD $600,000; second tranche expected to close on or before September 21, 2026
- Investors may watch for the second tranche closing and progress on the company's planned U.S. neuroimaging clinic opening
First Tranche Results and Structure of the Expanded Offering
The first tranche, which closed on September 10, 2026, generated gross proceeds of CAD $600,000, comprising CAD $285,000 from the sale of 712,500 Equity Units and CAD $315,000 from Debenture Units. The Second Tranche is expected to add CAD $250,000 of Equity Units and CAD $250,000 of Debenture Units. If completed as planned, the full offering would total CAD $1.1 million, consisting of CAD $535,000 from Equity Units and CAD $565,000 from Debenture Units combined across both tranches.
Equity Unit and Convertible Debenture Terms for Grey Matters Investors
Each Equity Unit is priced at CAD $0.40 and includes one Class A common share and one warrant exercisable at CAD $0.60 per share for 36 months from issuance. Each Debenture Unit comprises a CAD $1,000 convertible debenture and 2,198 common share purchase warrants. The debentures carry a 10% annual interest rate, payable semi-annually, with a 24-month maturity. Holders may convert principal and interest into common shares at CAD $0.455 per share. Debenture warrants carry an exercise price of CAD $0.55 per share, also for 36 months.
Proceeds Directed Toward Alzheimer's Detection Clinic Development in the U.S.
Grey Matters Health plans to deploy the offering proceeds to advance its Alzheimer's Disease program, specifically toward opening a U.S. brain-dedicated neuroimaging clinic offering PET scanning services for the early detection of Alzheimer's, frontotemporal dementia, Parkinson's, and Lewy body dementia. Additional use of proceeds includes general and administrative expenses and working capital. All securities issued are subject to a statutory hold period of four months plus one day from issuance under applicable Canadian securities legislation.



Please wait processing your request...